A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline

Clinical trial NCT00143299 · COMPLETED

Trial details

NCT number: NCT00143299
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2003-10-01
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.